2EWP

Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 0.247 
  • R-Value Work: 0.187 
  • R-Value Observed: 0.188 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.

Chao, E.Y.Collins, J.L.Gaillard, S.Miller, A.B.Wang, L.Orband-Miller, L.A.Nolte, R.T.McDonnell, D.P.Willson, T.M.Zuercher, W.J.

(2006) Bioorg Med Chem Lett 16: 821-824

  • DOI: 10.1016/j.bmcl.2005.11.030
  • Primary Citation of Related Structures:  
    2EWP

  • PubMed Abstract: 
  • The design and synthesis of 4-hydroxytamoxifen (4-OHT) derivatives are described. The binding affinities of these compounds toward the orphan estrogen-related receptor gamma and the classical estrogen receptor alpha demonstrate that analogs bearing hydroxyalkyl groups display improved binding selectivity profiles compared with that of 4-OHT ...

    The design and synthesis of 4-hydroxytamoxifen (4-OHT) derivatives are described. The binding affinities of these compounds toward the orphan estrogen-related receptor gamma and the classical estrogen receptor alpha demonstrate that analogs bearing hydroxyalkyl groups display improved binding selectivity profiles compared with that of 4-OHT. An X-ray crystal structure of one of the designed compounds bound to ERRgamma LBD confirms the molecular basis of the selectivity.


    Organizational Affiliation

    Discovery Research, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27709, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Estrogen-related receptor gammaA, B, C, D, E226Homo sapiensMutation(s): 0 
Gene Names: ESRRGERR3ERRG2KIAA0832NR3B3
UniProt & NIH Common Fund Data Resources
Find proteins for P62508 (Homo sapiens)
Explore P62508 
Go to UniProtKB:  P62508
PHAROS:  P62508
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP62508
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
TXF
Query on TXF

Download Ideal Coordinates CCD File 
F [auth A],
G [auth B],
H [auth C],
I [auth D],
J [auth E]
(Z)-4-(1-{4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL}-5-HYDROXY-2-PHENYLPENT-1-ENYL)PHENOL
C27 H31 N O3
ZVSFNBNLNLXEFQ-RQZHXJHFSA-N
 Ligand Interaction
Binding Affinity Annotations 
IDSourceBinding Affinity
TXF BindingDB:  2EWP IC50: min: 77, max: 2700 (nM) from 5 assay(s)
PDBBind:  2EWP IC50: 79 (nM) from 1 assay(s)
Binding MOAD:  2EWP IC50: 79 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 0.247 
  • R-Value Work: 0.187 
  • R-Value Observed: 0.188 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 106.876α = 90
b = 75.776β = 104.84
c = 185.092γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MAR345data collection
SCALEPACKdata scaling
AMoREphasing

Structure Validation

View Full Validation Report




Entry History 

Deposition Data

  • Deposited Date: 2005-11-04 
  • Released Date: 2006-05-09 
  • Deposition Author(s): Nolte, R.T.

Revision History  (Full details and data files)

  • Version 1.0: 2006-05-09
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2017-10-18
    Changes: Refinement description